Basic Information
Basic information for SNHG17-260-15aa
Peptide Name SNHG17-260-15aa
Genome Position chr20:38422712-38422756[-]
Species Human
Peptide Sequence MGLLCAEAPWDVLSS
Peptide Length 15
Unique No (SNHG17-221-15aa,SNHG17-232-15aa-1,SNHG17-233-15aa-2,SNHG17-234-15aa,SNHG17-237-15aa,SNHG17-238-15aa,SNHG17-245-15aa,SNHG17-251-15aa-2,SNHG17-253-15aa,SNHG17-256-15aa,SNHG17-265-15aa,SNHG17-273-15aa,SNHG17-274-15aa)
Grand Average of Hydropathicity 0.8067
Relative Molecular Mass 1844.04
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000196756;SNHG17
Transcript ID/Name ENST00000664964;SNHG17-260
Transcript Length 1291
Coding Ability 0.347
DNA Sequence Corresponding to Peptide ATGGGTCTGCTGTGTGCAGAGGCTCCATGGGATGTGTTGTCTTCA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :